Cargando…

Drugs for the overactive bladder: are there differences in persistence and compliance?

Detalles Bibliográficos
Autor principal: Andersson, Karl-Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503948/
https://www.ncbi.nlm.nih.gov/pubmed/28725606
http://dx.doi.org/10.21037/tau.2017.03.90
_version_ 1783249183014125568
author Andersson, Karl-Erik
author_facet Andersson, Karl-Erik
author_sort Andersson, Karl-Erik
collection PubMed
description
format Online
Article
Text
id pubmed-5503948
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-55039482017-07-19 Drugs for the overactive bladder: are there differences in persistence and compliance? Andersson, Karl-Erik Transl Androl Urol Editorial AME Publishing Company 2017-06 /pmc/articles/PMC5503948/ /pubmed/28725606 http://dx.doi.org/10.21037/tau.2017.03.90 Text en 2017 Translational Andrology and Urology. All rights reserved.
spellingShingle Editorial
Andersson, Karl-Erik
Drugs for the overactive bladder: are there differences in persistence and compliance?
title Drugs for the overactive bladder: are there differences in persistence and compliance?
title_full Drugs for the overactive bladder: are there differences in persistence and compliance?
title_fullStr Drugs for the overactive bladder: are there differences in persistence and compliance?
title_full_unstemmed Drugs for the overactive bladder: are there differences in persistence and compliance?
title_short Drugs for the overactive bladder: are there differences in persistence and compliance?
title_sort drugs for the overactive bladder: are there differences in persistence and compliance?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503948/
https://www.ncbi.nlm.nih.gov/pubmed/28725606
http://dx.doi.org/10.21037/tau.2017.03.90
work_keys_str_mv AT anderssonkarlerik drugsfortheoveractivebladderaretheredifferencesinpersistenceandcompliance